UBS analyst issues NEUTRAL recommendation for XPEV on September 9, 2026 10:21AM ET. The previous analyst recommendation was Neutral.XPEV was trading at $10.93 at issue of the analyst recommendation.The overall...
Jefferies analyst issues BUY recommendation for SMMT on September 9, 2026 10:41AM ET. The previous analyst recommendation was Buy.SMMT was trading at $17.28 at issue of the analyst recommendation.The overall...
Bernstein analyst issues OUTPERFORM recommendation for RIO on September 9, 2026 10:55AM ET. The previous analyst recommendation was Outperform.RIO was trading at $103.83 at issue of the analyst recommendation.The overall...
Citigroup analyst issues NEUTRAL recommendation for AU on September 9, 2026 09:27AM ET. The previous analyst recommendation was Underweight.AU was trading at $107.83 at issue of the analyst recommendation.The overall...
Citigroup analyst issues CAUTIOUS recommendation for CRH on September 9, 2026 09:40AM ET. The previous analyst recommendation was Buy.CRH was trading at $90.61 at issue of the analyst recommendation.The overall...
CLSA analyst issues OUTPERFORM recommendation for JP on September 9, 2026 06:25AM ET. The previous analyst recommendation was Outperform.JP was trading at $0.38 at issue of the analyst recommendation.The overall...
RBC Capital analyst issues OUTPERFORM recommendation for AZN on September 8, 2026 08:15PM ET. AZN was trading at $160.04 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
RBC Capital analyst issues SECTOR PERFORM recommendation for SNY on September 8, 2026 08:22PM ET. SNY was trading at $43.155 at issue of the analyst recommendation.The overall analyst consensus :...
BTIG analyst issues BUY recommendation for CAN on September 8, 2026 08:18PM ET. The previous analyst recommendation was Buy.CAN was trading at $0.3232 at issue of the analyst recommendation.The overall...
RBC Capital analyst issues SECTOR PERFORM recommendation for GSK on September 8, 2026 08:17PM ET. The previous analyst recommendation was Outperform.GSK was trading at $48.54 at issue of the analyst...
